$67B CVS deal to buy Aetna may hinge on antitrust approach

By

The health-care deal unveiled Sunday would create an industry giant with over $240 billion in annual sales with a hand in insurance, prescription drug plan administration, retail pharmacies and corner clinics. (Photo courtesy of CVS).

CVS‘ $67.5 billion takeover of Aetna will test the Trump administration’s approach to far-reaching corporate takeovers, just weeks after the U.S. government sued to block a major telecommunications merger, according to a story on www.chicagotribune.com

[uam_ad id=”54865″]


There are nearly two dozen CVS Pharmacy locations in Montgomery County.

The health-care deal unveiled Sunday would create an industry giant with over $240 billion in annual sales with a hand in insurance, prescription drug plan administration, retail pharmacies and corner clinics. The companies said the combination will save $750 million in costs and bring consumers better, more efficient health care.

In the past, deals combining companies up and down a chain of business — such as a supplier and a distributor — have been viewed as posing less anticompetitive risk than combinations of direct rivals. Last month, however, the Justice Department sued to block just such a “vertical” merger between AT&T and Time Warner, saying it would harm consumers and limit their media content options.

“We are obviously going to get some scrutiny,” said Aetna Chief Executive Officer Mark Bertolini. “We are prepared to deal with whatever comes along to make this work.”

To read the complete story click here.

[uam_ad id=”54875″]

 

Tags:

Stay Connected, Stay Informed

Subscribe for great stories in your community!

"*" indicates required fields

Hidden
MT Yes
This field is for validation purposes and should be left unchanged.
Advertisement